Functional redundancy of type I and type II receptors in the regulation of skeletal muscle growth by myostatin and activin A
Open accessThe DOI matches its Crossref record; 59 of the 60 references it cites were found in a registry or an index.
Abstract
Significance: Myostatin and activin A are secreted signaling molecules that act to limit skeletal muscle growth. Here, we show that myostatin and activin A utilize four receptor components to signal directly to muscle fibers. These findings have implications for strategies to target this signaling pathway for clinical applications to treat patients with muscle loss.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“We and others have previously demonstrated that growth differentiation factor-8 (GDF8; also known as myostatin) and activin A (ActA) are the two major ligands mediating the muscle-minimization actions of ActRIIA/B receptors22,26–30.”
From GDF8 and activin A blockade protects against GLP-1–induced muscle loss while enhancing fat loss in obese male mice and non-human primates (2025) · cites this paper as [29]
In the citing paper
“However, this protection from weight gain with muscle Acvr2a/b deletion is not as great as that seen in Mstn−/− mice, making it plausible that signaling through this pathway could still directly affect adipose tissue [30].”
From Antibody blockade of activin type II receptors preserves skeletal muscle mass and enhances fat loss during GLP-1 receptor agonism (2024) · cites this paper as [30]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guidelines for assessment of bone microstructure in rodents using micro–computed tomography
Bouxsein, M. L., Boyd, S. K., Christiansen, B. A., Guldberg, R. E., Jepsen, K. J., & Müller, R. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.141 · Cited by 4,433 · cited 1×
“Analysis of femurs and vertebrae was conducted using standard protocols, with a lower threshold of 2,485 Hounsfield units (HU) for femoral trabeculae, 4,932 HU for femoral cortex, and 3,078 HU for vertebral trabeculae (59).”
Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member
McPherron, A. C., Lawler, A. M., & Lee, S.-J. (1997) · Nature · doi:10.1038/387083a0 · Cited by 4,013
Self-citationDouble muscling in cattle due to mutations in the myostatin gene
McPherron, A. C., & Lee, S.-J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12457 · Cited by 2,039 · cited 1×
“The sequence of MSTN has been highly conserved through evolution, with the mature MSTN peptide being identical in species as divergent as humans and turkeys (3).”
Self-citationRegulation of myostatin activity and muscle growth
Lee, S.-J., & McPherron, A. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151270098 · Cited by 1,616 · cited 14×
“One possible candidate was BMPRII, although we were unable to detect significant binding of MSTN to BMPRII in transfected cells (18).”
InfluentialSelf-citationA deletion in the bovine myostatin gene causes the double–muscled phenotype in cattle
Grobet, L., Royo Martin, L. J., Poncelet, D., Pirottin, D., Brouwers, B., Riquet, J., Schoeberlein, A., Dunner, S., Ménissier, F., Massabanda, J., et al. (1997) · Nature Genetics · doi:10.1038/ng0997-71 · Cited by 1,556
Myostatin Mutation Associated with Gross Muscle Hypertrophy in a Child
Schuelke, M., Wagner, K. R., Stolz, L. E., Hübner, C., Riebel, T., Kömen, W., Braun, T., Tobin, J. F., & Lee, S.-J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040933 · Cited by 1,399
Self-citationClop, A., Marcq, F., Takeda, H., Pirottin, D., Tordoir, X., Bibé, B., Bouix, J., Caiment, F., Elsen, J.-M., Eychenne, F., et al. (2006) · Nature Genetics · doi:10.1038/ng1810 · Cited by 1,260 · cited 1×
“The function of MSTN has also been conserved, and targeted or naturally occurring mutations in MSTN have been shown to cause increased muscling in numerous species, including cattle (3–5), sheep (6), dogs (7), rabbits (8), rats (9), swine (10), goats (11), and humans (12).”
Mutations in myostatin ( GDF8 ) in Double-Muscled Belgian Blue and Piedmontese Cattle
Kambadur, R., Sharma, M., Smith, T. P. L., & Bass, J. J. (1997) · Genome Research · doi:10.1101/gr.7.9.910 · Cited by 1,204
Efficient in vivo manipulation of mouse genomic sequences at the zygote stage.
Lakso, M., Pichel, J. G., Gorman, J. R., Sauer, B., Okamoto, Y., Lee, E., Alt, F. W., & Westphal, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5860 · Cited by 1,125 · cited 1×
“Offspring from these matings were then bred with EIIa-Cre transgenic mice (58) in order to delete the neomycin resistance cassette in the germline.”
Activin-Binding Protein from Rat Ovary Is Follistatin
Nakamura, T., Takio, K., Eto, Y., Shibai, H., Titani, K., & Sugino, H. (1990) · Science · doi:10.1126/science.2106159 · Cited by 883 · cited 1×
“For example, the activities of both MSTN and activin A can be modulated extracellularly by naturally occurring inhibitory binding proteins, including follistatin (17, 18) and the follistatin-related protein, FSTL-3 or FLRG (19, 20).”
Cited by
Targeting the myostatin signaling pathway to treat muscle loss and metabolic dysfunction
Lee, S.-J. (2021) · Journal of Clinical Investigation · doi:10.1172/jci148372 · Cited by 143
“Studies in mice have demonstrated clearly that blocking signaling by ACVR2 and ACVR2B just in skeletal myofibers not only can induce significant muscle growth but also can reduce total body fat content and improve glucose metabolism (34).”
InfluentialSelf-citationNunn, E., Jaiswal, N., Gavin, M., Uehara, K., Stefkovich, M., Drareni, K., Calhoun, R., Lee, M., Holman, C. D., Baur, J. A., et al. (2024) · Molecular Metabolism · doi:10.1016/j.molmet.2024.101880 · Cited by 126
Myostatin: a skeletal muscle chalone
Lee, S.-J. (2023) · Annual Review of Physiology · doi:10.1146/annurev-physiol-012422-112116 · Cited by 84
Self-citationAbati, E., Manini, A., Comi, G. P., & Corti, S. P. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04408-w · Cited by 91
“Indeed, the two type I receptors, ALK4 and ALK5, seem to have a much greater expression in muscle mass than the two type II receptors, at least in rodent models [75].”
BackgroundSolagna, F., Tezze, C., Lindenmeyer, M. T., Lu, S. Y., Wu, G., Liu, S., Zhao, Y., Mitchell, R., Meyer, C., Omairi, S., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci135821 · Cited by 68
“Indeed, a recent study (69) showed how targeting the Acvr2b and Acvr2a in muscle leads to muscle hypertrophy.”
BackgroundThe role of TGF-β signaling in muscle atrophy, sarcopenia and cancer cachexia
Lan, X., Deng, C., Wang, Q., Zhao, L., Jiao, B., & Xiang, Y. (2024) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2024.114513 · Cited by 66
Mastaitis, J. W., Gomez, D., Raya, J. G., Li, D., Min, S., Stec, M., Kleiner, S., McWilliams, T., Altarejos, J. Y., Murphy, A. J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59485-9 · Cited by 53
Muscle-derived myostatin is a major endocrine driver of follicle-stimulating hormone synthesis
Ongaro, L., Zhou, X., Wáng, Y., Schultz, H., Zhou, Z., Buddle, E. R. S., Brûlé, E., Lin, Y., Schang, G., Hagg, A., et al. (2025) · Science · doi:10.1126/science.adi4736 · Cited by 53
Self-citationCancer cachexia: molecular basis and therapeutic advances
Tan, Y., Xue, R., Pan, Y., he, Z., Hu, X., Li, Y., Li, K., Zhang, X., Bian, X.-W., & Wang, B. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02331-7 · Cited by 67
Mangano, G. D., Fouani, M., Damico, D. C. S., Felice, V. D., & Barone, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063004 · Cited by 43
“Myostatin is synthesized and secreted primarily by skeletal muscle cells and signals through the activin-type II receptor (ActRII) [18].”
BackgroundResearch progress on sarcopenia in the musculoskeletal system
Mao, X., Lv, K., Qi, W., Cheng, W., Li, T., Sun, Y., Jin, H., Pan, H., & Wang, D. (2025) · Bone Research · doi:10.1038/s41413-025-00455-8 · Cited by 37
“109 Clinical evidence demonstrates that sterol supplementation effectively attenuates age-related declines in muscle mass and grip strength while increasing lean leg mass and limb strength in community-dwelling elderly males.”
Wang, X., Wei, Z., Gu, M., Zhu, L., Hai, C., Di, A., Wu, D., Bai, C., Su, G., Liu, X., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415707 · Cited by 29
“We found elevated glucose levels in the muscle of the Mstn−/− mice, whereas previous studies showed decreased blood glucose in Mstn−/− mice [50].”
ResultHillege, M. M., Shi, A., Galli, R., Wu, G., Bertolino, P., Hoogaars, W. M. H., & Jaspers, R. T. (2022) · eLife · doi:10.7554/elife.77610 · Cited by 29
Thürkauf, M., Lin, S., Oliveri, F., Grimm, D., Platt, R. J., & Rüegg, M. A. (2023) · Nature Communications · doi:10.1038/s41467-023-41769-7 · Cited by 27
The key role of myostatin b in somatic growth in fishes derived from distant hybridization
Liu, Q., Duan, L., Li, B., Zhang, X., Liu, F., Yu, J., Shu, Y., Hu, F., Lin, J., Xiong, X., et al. (2024) · Science China Life Sciences · doi:10.1007/s11427-023-2487-8 · Cited by 28
“Distant hybridization is a classical breeding technique (Liu et al., 2020; Liu et al., 2022).”
McIntosh, M. C., Sexton, C. L., Godwin, J. S., Ruple, B. A., Michel, J. M., Plotkin, D. L., Ziegenfuss, T. N., Lopez, H. L., Smith, R. C., Dwaraka, V. B., et al. (2023) · Cells · doi:10.3390/cells12060898 · Cited by 32
“, activation) of SMAD transcription factors [41].”
Hulmi, J. J., Nissinen, T. A., Penna, F., & Bonetto, A. (2021) · Cells · doi:10.3390/cells10030516 · Cited by 24
“However, previous evidence has highlighted how blockade of ACVR2 ligands can improve bone quantity and/or quality in different animal models by acting directly on bone [190].”
BackgroundLiu, Y., Lehar, A., Rydzik, R., Chandok, H., Lee, Y., Youngstrom, D. W., George, J., Matzuk, M. M., Germain‐Lee, E. L., & Lee, S. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2111401118 · Cited by 21
Self-citationActivation of β-catenin in mesenchymal progenitors leads to muscle mass loss
Kajabadi, N., Low, M., Jacques, E., Lad, H., Tung, L. W., Babaeijandaghi, F., Gamu, D., Zelada, D., Wong, C. K., Chang, C.-K., et al. (2023) · Developmental Cell · doi:10.1016/j.devcel.2023.02.009 · Cited by 23
Self-citationSkeletal Muscle and Kidney Crosstalk in Chronic Kidney Disease
Jenkin, K. A., & Perry, B. D. (2022) · Cellular Physiology and Biochemistry · doi:10.33594/000000578 · Cited by 18
Takayama, K., Hitachi, K., Okamoto, H., Saitoh, M., Odagiri, M., Ohfusa, R., Shimada, T., Taguchi, A., Taniguchi, A., Tsuchida, K., et al. (2022) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.1c00705 · Cited by 15
Murine Animal Models in Osteogenesis Imperfecta: The Quest for Improving the Quality of Life
Alcorta-Sevillano, N., Infante, A., Macías, I., & Rodríguez, C. I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010184 · Cited by 15
“Subsequently, the targeting of this pathway has been found to protect against muscle and skeletal loss under several conditions, such as aging and microgravity leading to disuse atrophy [114,115].”
BackgroundFunctionally diverse heteromeric traps for ligands of the transforming growth factor-β superfamily
Kumar, R., Grinberg, A. V., Li, H., Kuo, T., Sako, D., Krishnan, L., Liharska, K., Li, J., Grenha, R., Maguire, M. C., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-97203-9 · Cited by 14
Lian, J., Walker, R. G., D’Amico, A., Vujić, A., Mills, M. J., Messemer, K. A., Mendello, K. R., Goldstein, J. M., Leacock, K. A., Epp, S., et al. (2023) · Life Science Alliance · doi:10.26508/lsa.202201662 · Cited by 14
Swan, J., Szabó, Z., Peters, J., Kummu, O., Kemppi, A., Rahtu‐Korpela, L., Konzack, A., Hakkola, J., Pasternack, A. H., Ritvos, O., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116683 · Cited by 9
Michiue, K., Takayama, K., Taniguchi, A., Hayashi, Y., & Kogure, K. (2023) · Pharmaceuticals · doi:10.3390/ph16030397 · Cited by 9
Lev, R., Bar‐Am, O., Saar, G., Guardiola, O., Minchiotti, G., Peled, E., & Seliktar, D. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06645-2 · Cited by 8
“It functions as a co-receptor of Nodal and several other TGF-β family ligands [31 – 33].”
BackgroundFunctional replacement of myostatin with GDF-11 in the germline of mice
Lee, S., Lehar, A., Rydzik, R., Youngstrom, D. W., Bhasin, S., Liu, Y., & Germain‐Lee, E. L. (2022) · Skeletal Muscle · doi:10.1186/s13395-022-00290-z · Cited by 8
“myofibers [24] having reductions in total body fat.”
BackgroundSelf-citationCawthon, P. M., Patel, S., Newman, A. B., Bhasin, S., Peng, L., Tracy, R. P., Kizer, J. R., Lee, S., Ferrucci, L., Ganz, P., et al. (2023) · The Journals of Gerontology Series A · doi:10.1093/gerona/glad045 · Cited by 11
Self-citationEgerman, M. A., Zhang, Y., Donné, R., Xu, J., Gadi, A., McEwen, C., Salmon, H. A., Xiong, K., Bai, Y., Germino, M., et al. (2025) · Skeletal Muscle · doi:10.1186/s13395-025-00373-7 · Cited by 9
“Muscle mass is negatively regulated by myostatin (also known as growth and differentiation factor 8 or GDF8), Activin A (ActA), and GDF11 [4–9], all of which are part of a sub-class of TGFβ family proteins that have a common receptor system–they all bind the Activin type II receptors (ActRIIA or…”
The double mutations of acvr2aa and acvr2ba leads to muscle hypertrophy in zebrafish
Che, J., Hu, C., Wang, Q., Fan, C., Si, Y., Gong, X., & Bao, B. (2022) · Aquaculture and Fisheries · doi:10.1016/j.aaf.2022.03.007 · Cited by 9
Activins and Inhibins in Cardiovascular Pathophysiology
Tang, W., Gu, Z., Guo, J., Lin, M., Tao, H., Jia, D., & Jia, P. (2024) · Biomolecules · doi:10.3390/biom14111462 · Cited by 8
“Inhibiting activin production or activity promotes an increase in muscle volume and mass [114,115].”
Combined angiogenic and hypertrophic gene therapy enhances skeletal muscle growth
Männistö, A., Tonttila, K., Ortega‐Alonso, A., Nurmi, H. J., Uusitalo‐Kylmälä, L., Hemanthakumar, K. A., Saikkala, E., Myllykangas, S., Vertainen, S., Nissinen, T. A., et al. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00966.2024 · Cited by 8
Zuo, H., Jiang, W. J., Gao, J., Ma, Z., Li, C., Peng, Y., Jin, J., Zhan, X., Lv, W., Liu, X., et al. (2024) · Advanced Science · doi:10.1002/advs.202410953 · Cited by 11
Newman, A. B., Patel, S., Kizer, J. R., Lee, S., Bhasin, S., Cawthon, P. M., LeBrasseur, N. K., Tracy, R. P., Ganz, P., & Cummings, S. R. (2023) · The Journals of Gerontology Series A · doi:10.1093/gerona/glad019 · Cited by 10
Self-citationDietary Plant Extracts in Improving Skeletal Muscle Development and Metabolic Function
Xiang, J., Du, ., & Wang, H. (2022) · Food Reviews International · doi:10.1080/87559129.2022.2087669 · Cited by 9
“[23,24] Myostatin also interplays with PI3K/Akt/mTOR pathway.”
Shen, T., Zhang, H., Chang, H., Klausen, C., Huang, H., Jin, M. Y., & Leung, P. C. K. (2022) · Biology of Reproduction · doi:10.1093/biolre/ioac070 · Cited by 7
“Similarly, a recent study showed that type I and II receptors are equally functional in the activin-regulated muscle growth [41].”
BackgroundWu, H., Sun, H. Y., Ma, C., Lian, L., Lu, L., Xu, L., & Xu, L. (2021) · Animal Bioscience · doi:10.5713/ab.20.0712 · Cited by 6
Pancreatic cancer cachexia: A systemic consequence of multi-organ interactions
Xiao, A., Feng, Y., Yin, B., Zhang, J., Cao, Z., Liu, X., Liang, Y., & Wu, W. (2025) · hLife · doi:10.1016/j.hlife.2025.05.002 · Cited by 6
Richman, J. A., & Phelps, M. (2024) · Marine Biotechnology · doi:10.1007/s10126-024-10345-5 · Cited by 5
“In mammals, the activin type II receptors (A and B) have overlapping functions and can compensate for the loss of a single receptor in skeletal muscle (Lee et al. 2020).”
Myostatin is a major endocrine driver of follicle-stimulating hormone synthesisPreprint
Ongaro, L., Zhou, X., Wang, Y., Zhou, Z., Schultz, H., Buddle, E. R. S., Brûlé, E., Lin, Y., Schang, G., Castonguay, R., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.30.555595 · Cited by 5
“Myostatin is produced predominantly in skeletal muscle (38) and circulating levels of the protein are largely derived from this source, as shown in muscle-specific Mstn cKO mice (40).”
BackgroundSelf-citationShi, A., He, C., Otten, K., Wu, G., Forouzanfar, T., Wüst, R. C. I., & Jaspers, R. T. (2024) · Journal of Cellular Physiology · doi:10.1002/jcp.31418 · Cited by 3
“Simultaneous myofibre ‐ specific knockout of type I receptors of the TGF ‐ β family after 10 weeks increased muscle mass in fast ‐ type mice gastrocnemius medialis muscle by ~200%, while knockout of type II receptors only increased muscle mass by ~63% (Lee et al., 2020).”
InfluentialAslam, M. R., Bilal, M., Nawaz, A., Kado, T., Abe, S., Phuong, N. Q., Memoona, M., Khalid, S., Anh, L. D., Nishimura, A., et al. (2025) · Molecular Medicine · doi:10.1186/s10020-025-01393-1 · Cited by 3
“Further studies revealed that MSTN partially negatively regulates muscle mass, which also cooperates with activin A [21].”
InfluentialRazi, O., Shafei, A., Abdi, M., Saeidi, B., Farzanegi, P., Zamani, N., ALNasser, M. N., Hejazi, K., Almaqhawi, A., Saeidi, A., et al. (2026) · Nutrients · doi:10.3390/nu18030509 · Cited by 1
Ravindran, S. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2023335117 · Cited by 1
Shi, A., Hillege, M. M., Noort, W., Offringa, C., Wu, G., Forouzanfar, T., Hoogaars, W. M. H., Wüst, R. C. I., & Jaspers, R. T. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.30.555466 · Cited by 1
Shi, A., Hillege, M. M. G., Noort, W., Offringa, C., Wu, G., Tim, F., Hoogaars, W. M. H., Wüst, R. C. I., & Jaspers, R. T. (2026) · Communications Biology · doi:10.21203/rs.3.rs-5136404/v1 · Cited by 1
Xu, T., Xu, S., Ma, G., Chang, J., Zhang, C., Zhou, P., Wang, C., Xu, P., Yang, J., Hu, Y., et al. (2023) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/1574892818666230413082909
“Studies authenticate that the Smad signaling pathway is regulated by the TGF-β type II receptor, and the TGF-β type II receptor can be activated by binding to ligands Activin A and GDF-8 [29-31].”
BackgroundXia, P., Lee, S., Roh, K., Griffith, J. W., Zhou, Y., Guzman, E., Shi, Y., Yang, Z., Castro, C., Li, H., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-6306417/v1 · Cited by 1
Self-citationTargeting the Alk4 pathway protects against age-related bone lossPreprint
Maridas, D. E., Chim, S. M., Burton, K. M., Doren, E. V., Gamer, L., Kirshen, K., Keles, E., Avalos, K., Kethani, R. S., & Rosen, V. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.24.684408
Qiao, Y., Liu, G., Ong, M. T., Sun, H., So, H., & Wang, H. (2026) · iScience · doi:10.64898/2026.01.04.696800
Myostatin in the pituitary–muscle axis: Roles in health and disease
Iglesias, P. (2026) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endinu.2025.501757
Gerlach, I., Koch, M., Gatto, G., Lackmann, J., Lehmann, H. C., Schroeter, M., & Kohle, F. (2026) · Acta Neuropathologica Communications · doi:10.1186/s40478-026-02277-z
“This may also explain the striking effects of ActIIR inhibition on muscle hypertrophy in several animal models and human trials [43, 45, 46, 65, 71].”
Jacquez, Q., Peabody, J., Acosta, E. H., Chackerian, B., & Endicott, S. J. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.06.716693
Lev, R., Bar‐Am, O., Saar, G., Guardiola, O., Peled, E., Minchiotti, G., & Seliktar, D. (2026) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.6c00084
A Lineup for Next Anti-Obesity Medicines: Beyond Incretin-Based Pharmacotherapy
Lee, S. M., Song, H., & Kwon, Y. O.-S. (2026) · Pharmaceuticals · doi:10.3390/ph19071047
“Growth Differentiation Factor-8 (GDF8) and Activin A (ActA)-Blocking Antibodies GDF8 (or myostatin) and ActA have been reported as two major ligands that mediate the muscle-minimization actions of ActRIIA/B [182,183].”
Self-citationTargeting skeletal muscle wasting: emerging therapeutics and translational challenges
Roberts, B. M. (2026) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2026.131001
Author, P., Umesh, Verma, K., Singh, M., & Yadav, N. (2026) · Journal of Ecophysiology and Occupational Health · doi:10.18311/jeoh/2026/29502
Metadata
- Authors
- Lee, S.-J., Lehar, A., Liu, Y., Ly, C. H., Pham, Q.-M., Michaud, M., Rydzik, R., Youngstrom, D. W., Shen, M. M., Kaartinen, V., Germain-Lee, E. L., & Rando, T. A.
- Affiliations
- University of Connecticut (US)
- The Jackson Laboratory for Genomic Medicine (US)
- Stanford Medicine (US)
- Columbia University (US)
- University of Michigan (US)
- Department of Pediatrics, University of Connecticut School of Medicine, Farmington, CT 06030;
- VA Palo Alto Health Care System (US)
- Corresponding author
- Lee, Se-Jin
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2020-11-20
- Volume
- 117
- Issue
- 49
- Pages
- 30907-30917
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC7733802
- OpenAlex
- W3106391536
- Semantic Scholar
- c1e334b7787a8b6449f81488ecbf0e86104490e7
- Cited by
- 59
- References
- 60
- Citations by year
- 2026: 11 · 2025: 9 · 2024: 10 · 2023: 10 · 2022: 12 · 2021: 6 · 2020: 1
- FWCI
- 2.43
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- The Mouseion at the JAXlibrary (Jackson Laboratory) (submittedVersion, cc-by-nc-nd)
- Funders
- HHS | National Institutes of Health (R01AR060636, R01AG052962)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Keywords
- myostatin, activin A, skeletal muscle growth, TGF-beta signaling, ACVR2, ACVR2B, ALK4, ALK5, muscle mass, fat mass, glucose metabolism, high-fat diet, satellite cells, muscle regeneration, bone mineral density
- MeSH terms
- Animals, Mice, Inbred C57BL, Muscles, Organ Size, Muscle Fibers, Skeletal, Muscle Development, Activins, Activin Receptors, Type I, Activin Receptors, Type II, Myostatin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.